Combinational Immunotherapy of Cancer: Novel Targets, Mechanisms, and Strategies

482K

views

617

authors

85

articles

Editorial

11 August 2023

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies

Yanyang Nan

,

Dianwen Ju

and

Xuyao Zhang

1,499 views

0 citations

Editors

4

Xuyao Zhang

School of Pharmacy, Fudan University

Xian Zeng

Fudan University

Yubin Li

GlaxoSmithKline (United States)

Dianwen Ju

School of Pharmacy, Fudan University

Impact

Fetching...

About

Download the ebooks for this Research Topic:
Volume I.A: ¦PDF¦ ¦EPUB
Volume I.B: ¦PDF¦ ¦EPUB

Cancer immunotherapy, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) therapy, has revolutionized the paradigm in cancer treatment. However, the clinical outcome of immunotherapy varies considerably among patients and only a minority of patients achieve long-term clinical benefits. This is largely attributed to the fact that existing cancer immunotherapies, which concentrate on several classical targets (CTAL-4, PD-1/PD-L1, etc.) and limited types of immune cell populations (T cells), are insufficient to cope with the complexity of highly heterogeneous tumor microenvironment (TME). This calls for more efforts to not only expand our toolbox for manipulating anticancer immunity but also diversify our combinational strategies. To this end, it is urgent to deeper our understanding of cancer immunotherapy by using both experimental and computational methodologies from multi-scale perspectives: 1) novel targets from either tumor cells or non-tumor cells within TME (e.g., tumor intrinsic resistance drivers, new immune checkpoints, neoantigens), 2) in-depth characterization of more immune cell populations (e.g., macrophages, Tregs, B cells) and their interactions and dynamics within TME, 3) landscape of actionable targets in patient populations for combination design. These efforts will open the avenue of rational design of combinational immunotherapies, allowing researchers and clinicians to design novel targeting therapeutics or to optimally orchestrate combinatory strategies aiming to surmount resistance mechanisms and improve clinical outcomes.

This Research Topic aims at inspiring novel insights into the cancer immunity mechanisms, novel therapeutic targets, and effective combinational strategies of cancer immunotherapies. We welcome Original Research articles, Review articles, Mini Reviews, Case Reports, Clinical Trials, and Perspectives that address the fundamental understanding of mechanisms underlying cancer immunotherapy, as well as the therapeutic potential of novel combinational therapy.

Submissions may focus on, but are not limited to, the following subtopics:

1. Primary or acquired resistance mechanisms of cancer immunotherapies

2. Single-cell characterization of dynamic immune response

3. Mechanistic research targeting cytokines and signaling pathways within the tumor that lead to activation or inhibition of anti-tumor immunity

4. Multifunctional antibody/protein or engineered immune cells with potent efficacy

5. Novel cancer immunotherapy insights mining from Omics big data by interdisciplinary strategies such as computational biology, bioinformatics, and artificial intelligence

6. Case reports and clinical trials of new combinatory strategies for cancer treatment

Download ebook

PDF

EPUB

Share

Editors

Xuyao Zhang

School of Pharmacy, Fudan University

Xian Zeng

Fudan University

Yubin Li

GlaxoSmithKline (United States)

Dianwen Ju

School of Pharmacy, Fudan University

Impact

482,004 Total views

297,718 Article views

178,917 Article downloads

5,369 Topic views

Published In

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Frontiers in Oncology

Cancer Immunity and Immunotherapy

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic